Otsuka Holdings is a Japanese pharmaceutical company that operates in the Large Pharma sector. The company was founded in 1964 and has since grown to become one of the leading pharmaceutical companies in Japan. Otsuka Holdings is committed to providing innovative and high-quality products to improve the health and well-being of people around the world.

Decarbonisation is a key focus area for Otsuka Holdings. The company recognizes the importance of reducing greenhouse gas emissions to mitigate the impact of climate change. Otsuka Holdings has set a target to reduce its greenhouse gas emissions by 30% by 2030 compared to its 2013 baseline. The company is taking a multi-pronged approach to achieve this target, including improving energy efficiency, increasing the use of renewable energy, and promoting the use of low-carbon technologies.

Corporate energy is another important area for Otsuka Holdings. The company is committed to reducing its energy consumption and improving energy efficiency across its operations. Otsuka Holdings has implemented a number of initiatives to achieve this, including the installation of energy-efficient lighting, the use of energy-efficient equipment, and the implementation of energy management systems. The company has also implemented a number of employee engagement programs to encourage energy conservation and promote sustainability.

Corporate PPA (Power Purchase Agreement) is a key strategy for Otsuka Holdings to increase its use of renewable energy. A PPA is a contract between a renewable energy provider and a corporate buyer, where the buyer agrees to purchase a certain amount of renewable energy at a fixed price over a specified period of time. Otsuka Holdings has signed a number of PPAs with renewable energy providers to increase its use of renewable energy. The company is also exploring the possibility of developing its own renewable energy projects to further increase its use of renewable energy.

Renewable energy is a key focus area for Otsuka Holdings. The company recognizes the importance of transitioning to a low-carbon economy and is committed to increasing its use of renewable energy. Otsuka Holdings has set a target to increase its use of renewable energy to 30% of its total energy consumption by 2030. The company is investing in a range of renewable energy technologies, including solar, wind, and biomass. Otsuka Holdings is also exploring the use of innovative technologies such as hydrogen fuel cells to further increase its use of renewable energy.

In conclusion, Otsuka Holdings is a Japanese pharmaceutical company that operates in the Large Pharma sector. The company is committed to decarbonisation and is taking a multi-pronged approach to reduce its greenhouse gas emissions. Corporate energy is also a key focus area for Otsuka Holdings, and the company is implementing a range of initiatives to improve energy efficiency across its operations. Corporate PPA is a key strategy for Otsuka Holdings to increase its use of renewable energy, and the company is investing in a range of renewable energy technologies to achieve its target of increasing its use of renewable energy to 30% by 2030.